Curis (CRIS) Current Leases (2019 - 2026)
Curis (CRIS) reported Current Leases of $1.2 million for Q1 2026, down 5.53% on a YoY basis from $1.3 million in Q1 2025, and up 3.28% quarter-over-quarter from $1.2 million in Q4 2025.
Curis (CRIS) Current Leases (2019 - 2026) Analysis & Trends
Curis has reported Current Leases for 8 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 5.53% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 5.53% YoY), and the FY2025 full-year result was $1.2 million, down 10.93% from the prior year.
- Current Leases for Q1 2026 stood at $1.2 million, up from $1.2 million in the prior quarter.
- The five-year high for Current Leases was $1.3 million in Q1 2024, with the low at $824000.0 in Q1 2022.
- Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.2 million in 2026.
- Annual changes were most pronounced in 2022 — Current Leases soared 68.51% — and 2025, when it retreated 10.93%.
- Curis' Current Leases stood at $1.1 million in 2022, then climbed by 14.37% to $1.3 million in 2023, then rose by 2.38% to $1.3 million in 2024, then dropped by 10.93% to $1.2 million in 2025, then advanced by 3.28% to $1.2 million in 2026.
- The last three Current Leases figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 42,980.09 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 824,000.00 |
| Dec 31, 2021 | 682,000.00 |
| Sep 30, 2021 | 657,000.00 |
| Jun 30, 2021 | 632,000.00 |